By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Miltenyi Biotec, Inc. 

12740 Earhart Avenue

Auburn  California  95602  U.S.A.
Phone: 530-887-5301 Fax: 530-887-5302



Company News
Lentigen Technology, A Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma 7/20/2017 11:19:33 AM
After Filling 70 U.S. Positions This Year, Miltenyi Biotec Plans to Add 30 More U.S. Jobs in 2017 12/2/2016 7:23:34 AM
Miltenyi Biotec, Inc. Webinar Spotlights Advances In Translational And Basic T Cell Research 6/14/2016 9:25:50 AM
Miltenyi Biotec, Inc. And Cesca Therapeutics' Subsidiary Totipotentrx Announce Multi-Year Commercial Agreement For Bone Marrow Transplantation 10/28/2015 7:23:29 AM
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014 1:27:56 PM
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia 1/24/2014 6:32:11 AM
Miltenyi Biotec, Inc. Acquires Owl biomedical, Inc. 4/23/2013 12:02:47 PM
Miltenyi Biotec, Inc. Partners With Terso Solutions, Inc. for a Fully Automated, On-Site Inventory Management Program 4/3/2013 11:45:48 AM
Automated Cell Biology Workflows with Tecan And Miltenyi Biotec, Inc. 8/17/2010 11:36:40 AM
Miltenyi Biotec, Inc.: Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells 10/29/2009 9:45:35 AM